$ELOX Eloxx Pharmaceuticals, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Eloxx Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Eloxx Pharmaceuticals, Inc. for free.

CIK Number: 0001035354
IRS Number: 841368850
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Trading Symbol: ELOX
Company Address: 950 WINTER STREET WALTHAM 02451
Phone number: 858-909-0749
Former name: NAVA LEISURE USA INC, date of change: 1997-03-10
Former name: SENESCO TECHNOLOGIES INC, date of change: 1999-10-06
Former name: Sevion Therapeutics, Inc., date of change: 2014-09-30

Market Capitalization: $4.75M
Prev close: $0.23
Average Daily Volume: 35,194
Days Low: $0.00
Year Low: $0.08
Year High: $0.39

Eloxx Pharmaceuticals, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 20 2021ELOXEloxx Pharmaceutic ...PAREKH RAJESH BOption ExerciseA1.483,3344,9343,334
May 20 2021ELOXEloxx Pharmaceutic ...Kariv TomerOption ExerciseA1.4820,00029,60020,000
May 20 2021ELOXEloxx Pharmaceutic ...Seehra JasbirOption ExerciseA1.4820,00029,60020,000
May 18 2021ELOXEloxx Pharmaceutic ...MODUR VIJAYHEAD OF R&DOption ExerciseA1.41496,204699,648496,204
May 17 2021ELOXEloxx Pharmaceutic ...PAREKH RAJESH BDirectorBuyP1.352,381,8903,215,5524,827,1292.4 M to 4.8 M (+97.41 %)
May 17 2021ELOXEloxx Pharmaceutic ...PAREKH RAJESH BDirectorBuyP1.3584,776114,448171,80787 K to 171.8 K (+97.41 %)
May 17 2021ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerBuyP1.35592,592799,999616,59224 K to 616.6 K (+2,469.13 %)
May 17 2021ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerBuyP1.351,422,2221,920,0001,989,551567.3 K to 2 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerBuyP1.352,630,4873,551,1573,679,7971 M to 3.7 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerBuyP1.351,280,6241,728,8421,791,470510.8 K to 1.8 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorBuyP1.35592,592799,999616,59224 K to 616.6 K (+2,469.13 %)
May 17 2021ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorBuyP1.351,422,2221,920,0001,989,551567.3 K to 2 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorBuyP1.352,630,4873,551,1573,679,7971 M to 3.7 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorBuyP1.351,280,6241,728,8421,791,470510.8 K to 1.8 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Kariv TomerDirectorBuyP1.35592,592799,999616,59224 K to 616.6 K (+2,469.13 %)

View all Eloxx Pharmaceuticals, Inc. insider transactions.